Science study unveils Virtual Biotech, a multi-agent AI system for drug development decisions
james_y_zou · x · 2026-09-23
A new study in Science presents Virtual Biotech, a multi-agent AI system designed to inform drug-development decisions. By combining diverse biomedical and clinical evidence on a unified platform, the system can surface therapeutic opportunities that would otherwise be missed — a notable example of AI agents operating in a high-stakes biomedical research domain.
More from Research
- Stanford's DyCraft Uses Agentic Decomposition to Cut Physical Errors in Long-Horizon 4D Scene Generation — StanfordUniversity · 2026-11-11
- Bert Chan on His Unconventional Path from Side-Projects to the ALife Institute — BertChakovsky · 2026-11-11
- CGM Study of 62,000 People: Average Glucose Beats HgbA1C at Detecting High Insulin — arjunrajlab · 2026-11-11
- First open dictation benchmark: 761 recordings across 10 apps, Wispr Flow 79% vs Apple 35% — rohanpaul_ai · 2026-11-11
- Boltz models showcased at MSK Cancer Center for accelerating early-stage drug discovery — charlieharris01 · 2026-11-11
- Carlman: a Pac-Man-style game where all characters are Lenia cellular-automata solitons — BertChakovsky · 2026-11-11